Attema Brecht, de la Rosa Rodriguez Montserrat A, van Schothorst Evert M, Grefte Sander, Hooiveld Guido Jej, Kersten Sander
Nutrition, Metabolism and Genomics Group, Division of Human Nutrition and Health, Wageningen University, Stippeneng 4, 6708 WE Wageningen, the Netherlands.
Human and Animal Physiology, Wageningen University, Wageningen, the Netherlands.
Mol Metab. 2025 Feb;92:102092. doi: 10.1016/j.molmet.2024.102092. Epub 2024 Dec 31.
The peroxisome proliferator-activated receptor-alpha (PPARα) plays a central role in lipid metabolism in the liver by stimulating the expression of hundreds of genes. Accordingly, regulation by PPARα could be a screening tool to identify novel genes involved in hepatic lipid metabolism. Previously, the mitochondrial transporter SLC25A47 was suggested to play a role in energy metabolism and liver-specific uncoupling, but further research is lacking.
We explored the potential role of SLC25A47 through in vitro studies and using mice overexpressing and lacking SLC25A47.
SLC25A47 was identified as a PPARα-regulated and fasting-induced gene in human and mouse hepatocytes. Adenoviral-mediated overexpression of SLC25A47 minimally impacted metabolic parameters during fasting and high-fat feeding. During high-fat feeding, SLC25A47 ablation also did not influence any metabolic parameters, apart from a minor improvement in glucose tolerance. In fasted mice, SLC25A47 ablation was associated with modest, reproducible, and likely indirect reductions in plasma triglycerides and glycerol. SLC25A47 ablation did not influence energy expenditure. Depending on the nutritional status, metabolomic analysis showed modest alterations in plasma, liver, and hepatic mitochondrial levels of various metabolites related to amino acid metabolism, TCA cycle, and fatty acid metabolism. No major and consistent alterations in levels of specific metabolites were found that establish the substrate for and function of SLC25A47.
Collectively, our results hint at a role of SLC25A47 in amino acid and fatty acid metabolism, yet suggest that SLC25A47 is dispensable for hepatic lipid homeostasis during fasting and high-fat feeding.
过氧化物酶体增殖物激活受体α(PPARα)通过刺激数百种基因的表达,在肝脏脂质代谢中发挥核心作用。因此,PPARα介导的调控可能是一种筛选参与肝脏脂质代谢新基因的工具。此前,线粒体转运体SLC25A47被认为在能量代谢和肝脏特异性解偶联中发挥作用,但仍缺乏进一步研究。
我们通过体外研究以及使用过表达和缺失SLC25A47的小鼠,探究了SLC25A47的潜在作用。
在人和小鼠肝细胞中,SLC25A47被鉴定为PPARα调控且受禁食诱导的基因。腺病毒介导的SLC25A47过表达对禁食和高脂喂养期间的代谢参数影响极小。在高脂喂养期间,SLC25A47缺失除了对葡萄糖耐量有轻微改善外,也未影响任何代谢参数。在禁食小鼠中,SLC25A47缺失与血浆甘油三酯和甘油的适度、可重复且可能是间接的降低有关。SLC25A47缺失不影响能量消耗。根据营养状况,代谢组学分析显示,与氨基酸代谢、三羧酸循环和脂肪酸代谢相关的各种代谢物在血浆、肝脏和肝线粒体水平上有适度改变。未发现特定代谢物水平有重大且一致的改变,无法确定SLC25A47的底物和功能。
总体而言,我们的结果提示SLC25A47在氨基酸和脂肪酸代谢中发挥作用,但表明在禁食和高脂喂养期间,SLC25A47对肝脏脂质稳态并非必不可少。